As a graduate student at Stanford University in the early 1990s, Jonathan Eisen convinced a friend with access to one of the first automated DNA sequencers to run 10,000 base pairs for him. "Doing it ...

Smith Lloyd M. Smith joined Lee Hood?s CalTech laboratory in 1982 with the idea that he would finally get to do ?real biology.? Having come from a chemistry background, people suggested that he learn ...

The Human Genome project set out to sequence all of the 3 billion nucleotides in the human genome. Exactly how was this daunting task done with such incredible speed and accuracy? In 1986, a ...

The fully automated sequencer DNBSEQ-T20×2 processes six slides per run using robotic integration of all genetic sequencer components. It addresses all high-throughput sequencing requirements in ...

DNA sequencing is an indispensable laboratory ... Huang is leading his team to develop an automated microfluidic device and prototype. Early data show comparable results that could place ECC ...

Improvements in methodology have dramatically dropped the cost of DNA sequencing in the last decade. In 2007, it cost around $10 million dollars to sequence a single genome. Today, there are ...

On Tuesday, researchers from firmware security firm Eclypsium called out one of them: the Illumina iSeq 100, a DNA sequencer that's a staple at 23andMe and thousands of other gene-sequencing ...

which commercialized the ABI automated DNA synthesizer, and Amgen, one of the first biotechnology companies. The “Gene Machine” gave labs across the world routine access to pure oligonucleotides, ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Eclypsium security researchers have uncovered UEFI vulnerabilities in the Illumina iSeq 100 DNA sequencer, but the broader issue involves the device development process at large. In highlighting ...

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.